EPS: As of FY2025 Q3, the actual value is USD 0.EBIT: As of FY2025 Q3, the actual value is USD -530.27 K.<h3>Segment Revenue</h3><ul><li>The company did not report any sales revenue for the periods ended March 31, 2025, and 2024, as it is a development-stage enterprise with a limited operating history and operating losses since its inception.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: The net loss for the nine months ended March 31, 2025, was - $1,319,759, compared to - $1,933,003 for the same period in 2024, showing a decrease of $613,244.</li><li>Operating Expenses: Total operating expenses for the nine months ended March 31, 2025, were $1,153,296, compared to $1,011,797 for the same period in 2024, an increase of $141,499.</li><li>Consulting and Advisory Fees: Increased to $266,720 for the nine months ended March 31, 2025, from $193,995 in 2024.</li><li>Related Party Consulting Fees: Increased to $364,500 for the nine months ended March 31, 2025, from $264,000 in 2024.</li><li>General and Administrative Expenses: Increased to $304,153 for the nine months ended March 31, 2025, from $193,557 in 2024.</li><li>Professional Fees: Decreased to $161,123 for the nine months ended March 31, 2025, from $212,986 in 2024.</li><li>Research and Development Expenses: Decreased to $56,800 for the nine months ended March 31, 2025, from $147,259 in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: Net cash used in operating activities was - $1,116,530 for the nine months ended March 31, 2025, compared to - $1,059,894 for the same period in 2024.</li><li>Financing Activities: The company received $517,000 from convertible bridge loans during the nine months ended March 31, 2025.</li></ul><h3>Unique Metrics</h3><ul><li>Convertible Notes Issued: During the nine months ended March 31, 2025, the company issued convertible notes totaling $517,000.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to develop and commercialize eco-friendly advanced materials, particularly in nanotechnology, with potential applications across various industries. It aims to establish production capabilities for its NEXBOARD™ product and explore manufacturing and branding opportunities.</li><li>Non-Core Business: In aerospace, the company seeks to acquire and commercialize high-growth-potential technologies, including next-generation air and spacecraft, through acquisitions, joint ventures, and strategic investments.</li><li>Priority: The company is focused on raising capital through the issuance of common stock and debt to fund operations and eventually generate revenue through its business.</li></ul>

Xeriant, Inc. | 10-Q: FY2025 Q3 EPS: USD 0